Forvis Wealth Advisors, LLC Merck & Co., Inc. Transaction History

Forvis Wealth Advisors, LLC

$3.96 Billion
Q2 2024

A detailed history of Forvis Wealth Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 56,986 shares of MRK stock, worth $6.6 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

56,986

Previous 54,688 4.2%

Holding current value

$6.6 Million

Previous $7.22 Million 2.25%

% of portfolio

0.18%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $284,492 - $305,542	2,298 Added 4.2%	56,986 $7.05 Million
Q1 2024 Apr 19, 2024	SELL	$113.24 - $131.95 $390,338 - $454,831	-3,447 Reduced 5.93%	54,688 $7.22 Million
Q4 2023 Jan 11, 2024	SELL	$100.18 - $109.02 $277,999 - $302,530	-2,775 Reduced 4.56%	58,135 $6.34 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $1.83 Million - $2.04 Million	-17,808 Reduced 22.62%	60,910 $6.27 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $1.96 Million - $2.13 Million	18,024 Added 29.7%	78,718 $9.08 Million
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $230,276 - $256,941	2,237 Added 3.83%	60,694 $6.46 Million
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $107,551 - $137,895	-1,230 Reduced 2.06%	58,457 $6.48 Million
Q3 2022 Oct 13, 2022	BUY	$84.53 - $94.96 $129,753 - $145,763	1,535 Added 2.64%	59,687 $5.14 Million
Q2 2022 Jul 22, 2022	BUY	$83.49 - $94.64 $1.48 Million - $1.67 Million	17,677 Added 43.67%	58,152 $5.3 Million
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $244,200 - $273,732	3,322 Added 8.94%	40,475 $3.32 Million
Q4 2021 Jan 14, 2022	BUY	$72.28 - $90.54 $111,961 - $140,246	1,549 Added 4.35%	37,153 $2.85 Million
Q3 2021 Oct 14, 2021	BUY	$71.68 - $78.83 $61,214 - $67,320	854 Added 2.46%	35,604 $2.67 Million
Q2 2021 Jul 14, 2021	SELL	$70.31 - $77.77 $60,115 - $66,493	-855 Reduced 2.4%	34,750 $2.7 Million
Q1 2021 Apr 23, 2021	SELL	$68.86 - $81.11 $646,664 - $761,704	-9,391 Reduced 20.87%	35,605 $2.75 Million
Q4 2020 Jan 22, 2021	BUY	$71.77 - $79.65 $192,200 - $213,302	2,678 Added 6.33%	44,996 $3.68 Million
Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $76,180 - $86,350	1,041 Added 2.52%	42,318 $3.51 Million
Q2 2020 Jul 15, 2020	BUY	$70.42 - $80.13 $378,155 - $430,298	5,370 Added 14.96%	41,277 $3.19 Million
Q1 2020 Apr 10, 2020	BUY	$63.36 - $87.82 $296,778 - $411,348	4,684 Added 15.0%	35,907 $2.76 Million
Q4 2019 Jan 13, 2020	BUY	$77.58 - $87.54 $81,303 - $91,741	1,048 Added 3.47%	31,223 $2.84 Million
Q3 2019 Oct 29, 2019	SELL	$76.08 - $82.93 $50,745 - $55,314	-667 Reduced 2.16%	30,175 $2.54 Million
Q2 2019 Jul 10, 2019	SELL	$69.84 - $81.59 $110,836 - $129,483	-1,587 Reduced 4.89%	30,842 $2.59 Million
Q1 2019 Apr 10, 2019	BUY	$69.58 - $79.36 $1.07 Million - $1.22 Million	15,326 Added 89.61%	32,429 $2.7 Million
Q4 2018 Jan 15, 2019	SELL	$65.24 - $75.71 $720,445 - $836,065	-11,043 Reduced 39.23%	17,103 $1.31 Million
Q3 2018 Oct 09, 2018	BUY	$57.69 - $67.84 $115,380 - $135,680	2,000 Added 7.65%	28,146 $2 Million
Q2 2018 Jul 13, 2018	BUY	$50.83 - $59.72 $34,106 - $40,072	671 Added 2.63%	26,146 $1.59 Million
Q1 2018 May 25, 2018	BUY	$50.96 - $59.23 $1,426 - $1,658	28 Added 0.11%	25,475 $1.39 Million
Q1 2018 Apr 20, 2018	BUY	$50.96 - $59.23 $491,967 - $571,806	9,654 Added 61.13%	25,447 $1.5 Million
Q4 2017 Jan 18, 2018	SELL	$51.62 - $61.64 $198,788 - $237,375	-3,851 Reduced 19.6%	15,793 $889,000
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $1.15 Million - $1.24 Million	19,644	19,644 $1.26 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $293B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.

Account

Forvis Wealth Advisors, LLC Merck & Co., Inc. Transaction History